Cutaneous vasculitis after COVID‐19 vaccination in a 41‐year‐old male

Abstract

Abstract Leukocytoclastic vasculitis could be a possible adverse event of different SARS‐CoV‐2 vaccines. Clinicians and manufacturers should be aware of this adverse event for appropriate diagnosis and treatment.

Keywords

• COVID‐19 infection
• cutaneous vasculitis
• leukocytoclastic vasculitis
• SARS‐CoV‐2 vaccine